PC-002L

N/A

Report date: 2024/12/23 10:25:58

Base Information

Drug NamePC-002L
Drug Alias NamePC-002LPC002L
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMyc proto-oncogene protein inhibitorsBaculoviral IAP repeat-containing protein 5 inhibitors
TargetsMyc proto-oncogene proteinBaculoviral IAP repeat-containing protein 5
Therapy Area/IndicationsSmall Cell Lung CarcinomaLeukemia, Lymphocytic, Chronic, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesCothera Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesCothera Bioscience Inc
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung CarcinomaLeukemia, Lymphocytic, Chronic, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A